(116 days)
The proposed Gryphon T and P BR Anchors are intended for:
Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction;
Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair;
Knee: Medial Collateral Ligament Repair, Lateral Collateral Ligament Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis;
Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament Reconstruction;
Hip: Capsular repair, acetabular labral repair.
The proposed Gryphon T and P BR Anchors are absorbable suture anchors manufactured of “Biocryl Rapide” material. The anchor comes preloaded on a disposable inserter assembly and is intended for fixation of size #2 suture to bone. The suture option is provided without needles. The Gryphon T and P BR Anchors are provided as size 3.0 mm. Each Gryphon T or P BR Anchor is provided sterile and is for single patient use only.
Here's an analysis of the provided text regarding the acceptance criteria and study information for the Gryphon T and P BR Anchors:
1. Table of Acceptance Criteria and Reported Device Performance
The provided text does not explicitly state specific numerical acceptance criteria for the Gryphon T and P BR Anchors. Instead, it broadly states that "Results of performance and safety testing have demonstrated that the proposed devices are suitable for their intended use."
The performance testing mentioned is "pull-out performance testing of the sample anchors under real-time aged conditions out to 26 weeks to show that the device meets its product specifications."
Without specific numerical criteria (e.g., "minimum pull-out strength of X Newtons for Y weeks"), a direct comparison table cannot be created.
However, based on the description, a conceptual table would look like this:
| Acceptance Criteria Category | Specific Acceptance Criteria (Not explicitly stated in text) | Reported Device Performance |
|---|---|---|
| Pull-out Performance | (e.g., Minimum pull-out strength at various time points) | Device meets product specifications for pull-out performance under real-time aged conditions out to 26 weeks. |
| Safety | (e.g., Biocompatibility, sterility, absence of adverse reactions) | Device is shown to be safe for its intended use. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: The text mentions "pull-out performance testing of the sample anchors." It does not specify the exact number (sample size) of anchors used in this testing.
- Data Provenance: The data provenance is internal testing conducted by the manufacturer, DePuy Mitek. The provided document does not indicate the country of origin of the data beyond the company's location in Raynham, MA, USA. It is a prospective study (performance testing of the new device).
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This section is not applicable to the provided information. The study described is a mechanical performance study (pull-out strength), not a study requiring expert interpretation of medical images or patient outcomes to establish ground truth. The "ground truth" for this type of study is the measured physical performance (e.g., force required for pull-out).
4. Adjudication Method for the Test Set
This section is not applicable. Adjudication methods (like 2+1, 3+1) are typically used in clinical studies or studies involving human expert interpretation to resolve discrepancies in diagnoses or assessments. Since this is a mechanical performance test, there is no human interpretation or adjudication involved in establishing the test results.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. The provided information describes mechanical performance testing of the device itself, not a study comparing human reader performance with or without AI assistance.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
This section is not applicable. The device described is a physical bone anchor, not an AI algorithm. Therefore, "standalone algorithm" performance is irrelevant.
7. The Type of Ground Truth Used
The ground truth used for this performance study is objective physical measurement. Specifically, it refers to the measured pull-out performance of the anchors, compared against the "product specifications." This is a direct measurement of the device's mechanical properties, not a subjective assessment, pathology, or outcomes data in the clinical sense.
8. The Sample Size for the Training Set
This section is not applicable. This is a mechanical device, not a machine learning model, so there is no concept of a "training set" for an algorithm.
9. How the Ground Truth for the Training Set Was Established
This section is not applicable. As there is no training set for an algorithm, there is no ground truth to be established for it.
{0}------------------------------------------------
SECTION 2 – 510(k) SUMMARY
APR-30 2010
| Submitter's Name and Address: | DePuy Miteka Johnson & Johnson company325 Paramount DriveRaynham, MA 02767 |
|---|---|
| Contact Person | Ruth ForstadtRegulatory Affairs ManagerDePuy Mitek, Inc.a Johnson & Johnson company325 Paramount DriveRaynham, MA 02767, USATelephone: 508-977-3988Facsimile: 508-977-6955e-mail: rforstad@its.jnj.com |
| Name of Medical Device | Classification Name: Single/multiple component metallic bone fixation appliances and accessoriesCommon/Usual Name: Bone AnchorProprietary Name: Gryphon T and P BR Anchors |
| Substantial Equivalence | The proposed Gryphon T and P BR Anchors are substantially equivalent to:K090124 Gryphon P BR Anchor (March 11, 2009); K073412 Gryphon BR and Healix BR Anchors (January 17, 2008). The proposed Gryphon T and P BR Anchors are also similar to:K071481 Healix PEEK Anchor (August 09, 2007) |
| Device Classification | These devices carry an FDA product code MAI and are classified as single/multiple component metallic bone fixation appliances and accessories under 21 CFR 888.3030. |
| Device Description | The proposed Gryphon T and P BR Anchors are absorbable suture anchors manufactured of “Biocryl Rapide” material. The anchor comes preloaded on a disposable inserter assembly and is intended for fixation of size #2 suture to bone. The suture option is provided without needles. The Gryphon T and P BR Anchors are provided as size 3.0 mm. Each Gryphon T or P BR Anchor is provided sterile and is for single patient use only. |
| Indications for Use | The proposed Gryphon T and P BR Anchors are intended for:Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction;Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair;Knee: Medial Collateral Ligament Repair, Lateral Collateral Ligament Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis;Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament Reconstruction;Hip: Capsular repair, acetabular labral repair. |
| Safety and Performance | Results of performance and safety testing have demonstrated that the proposed devices are suitable for their intended use.Verification of the Gryphon BR Anchors includes pull-out performance testing of the sample anchors under real-time aged conditions out to 26 weeks to show that the device meets its product specifications.Based on the indications for use, technological characteristics, and comparison to the predicate devices, the proposed Gryphon T and P BR Anchors have shown to be substantially equivalent to the predicate devices under the Federal Food, Drug and Cosmetic Act. |
Confidential
ﺘﻌﻠﻴﺎﺕ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪ
{1}------------------------------------------------
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
DePuy Mitek % Ruth Forstadt Regulatory Affiars Manager 325 Paramount Drive Raynham, MA 02767
APR 3 0 2010
Re: K100012
Trade/Device Name: Gryphon T and P BR Anchors Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: MAI Dated: April 26, 2010 Received: April 27, 2010
Dear Ms. Forstadt:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
{3}------------------------------------------------
Page 2 - Mr. Ruth Forstadt
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference.to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Barbara BucheuD
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K100012 (pg 1/1)
Indications for Use
510(k) Number (if known):
Device Name: Gryphon T and P BR Anchors
Indications for Use:
- Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction;
Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair;
Knee: Medial Collateral Ligament Repair, Lateral Collateral Ligament Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis;
Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament Reconstruction; Elbow:
Hip: Capsular repair, acetabular labral repair.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Smith for nxn
(Division Sign-Off)
Division of Surgical, Orthope and Restorative Devices
Page 1 of 1
510(k) Number K110012
Premarket Notification - Traditional Gryphon T and P BR Anchors - Hip Indication
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.